Overview
Study information
Network: | CAVD |
Grant Affiliation: | NA |
Strategy: | Protein and peptide vaccines |
Study Type: | Pre-Clinical NHP |
Species: | Rhesus macaque |
Stage: | In progress |
Study Start Date: | NA |
Study Made Public: | NA |
Title
Hydrogel sustained-release antigen delivery
Description
CAVD 901 is a pre-clinical non-human primate study to evaluate novel formulations of an HIV protein vaccine with a slow delivery mode.
Sign in to see full information about this study and to download study data.
Products
Product info coming soon!Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.